8.5 Management of Common Discomforts & Physiologic Changes in Pregnancy

Maternal Systemic Physiological Adaptations

Pregnancy triggers profound, coordinated anatomical and endocrinological alterations across every maternal organ system. These adaptations support the metabolic demands of the growing fetoplacental unit and protect against intrapartum blood loss.

Cardiovascular Adaptations

• Plasma Volume & Hemodilution: Maternal plasma volume expands by 40% to 50% (~1,200 to 1,500 mL) above non-pregnant baselines. In contrast, erythrocyte mass increases by only 20% to 30% (~300 to 450 mL) via erythropoietin stimulation. This marked disparity produces physiological hemodilution ("physiologic anemia of pregnancy"), where hematocrit declines to ~32% to 34% and hemoglobin reaches a nadir of 10.5 to 11.0 g/dL late in the second trimester.
• Cardiac Output (CO): Increases by 30% to 50%. Early in pregnancy, this rise is driven primarily by increased stroke volume (SV) (+25% to 30%). Later in gestation, maternal heart rate increases by 10 to 15 beats per minute, sustaining elevated cardiac output.
• Systemic Vascular Resistance (SVR) & Blood Pressure: High circulating levels of progesterone, prostacyclin (PGI₂), and nitric oxide induce vascular smooth muscle relaxation, dramatically lowering SVR. Blood pressure declines early in pregnancy, reaching a nadir at 24 to 28 weeks (systolic drops 5–10 mmHg, diastolic drops 10–15 mmHg), before gradually returning to pre-pregnancy baselines by term.
• Auscultatory Findings: A physiologic grade I–II/VI systolic ejection murmur heard along the left sternal border is present in >90% of pregnant women due to hyperdynamic flow across the aortic and pulmonic valves. An S3 gallop is common. In contrast, diastolic murmurs are ALWAYS pathologic and mandate formal echocardiography.
• Supine Hypotensive Syndrome: In late gestation, the gravid uterus compresses the inferior vena cava (IVC) and descending aorta when the patient is in the supine position. This impedes venous return to the right atrium, precipitating sudden drops in cardiac output, arterial hypotension, syncope, and reduced uteroplacental perfusion. It is promptly corrected by repositioning the patient in the left lateral tilt position.

Respiratory Adaptations

• Progesterone & Hyperventilation: Progesterone acts directly on the hypothalamic respiratory center, lowering the threshold and increasing central sensitivity to carbon dioxide.
• Ventilatory Mechanics: Tidal volume (TV) increases by 30% to 40% without a significant change in respiratory rate, driving a 30% to 50% increase in minute ventilation. Vital capacity remains unchanged, while functional residual capacity (FRC) and residual volume decline by 20% due to diaphragmatic elevation by the gravid uterus.
• Acid-Base Homeostasis: Maternal hyperventilation produces a state of chronic compensated respiratory alkalosis:
  • Arterial pH: 7.40 to 7.45
  • Arterial PaCO₂: 27 to 32 mmHg (non-pregnant baseline: 35 to 45 mmHg)
  • Serum Bicarbonate (HCO₃⁻): 18 to 22 mEq/L (non-pregnant baseline: 22 to 26 mEq/L) via compensatory renal excretion.
  • This lowered maternal PaCO₂ creates a favorable maternal-fetal gradient that facilitates passive transplacental diffusion of fetal carbon dioxide into maternal blood.
• Dyspnea of Pregnancy: Experienced by up to 60% to 70% of healthy pregnant women, dyspnea reflects central awareness of hyperventilation rather than cardiopulmonary compromise.

Renal & Urinary Adaptations

• Renal Hemodynamics: Renal blood flow (RBF) and Glomerular Filtration Rate (GFR) increase by ~50% beginning in early pregnancy, driven by relaxin and nitric oxide.
• Solute Excretion & Laboratory Baselines: Elevated GFR accelerates the clearance of urea and creatinine. Consequently, normal pregnancy serum baselines are significantly lower than non-pregnant values:
  • Normal pregnancy Serum Creatinine: 0.4 to 0.6 mg/dL (non-pregnant: 0.7 to 1.2 mg/dL).
  • Normal pregnancy BUN: 8 to 10 mg/dL.
  • A serum creatinine ≥0.8 mg/dL is abnormal in pregnancy and reflects underlying renal impairment!
• Physiologic Hydronephrosis: Dilation of the renal calyces, pelves, and ureters occurs in >80% of gravidas. Dilation is markedly more pronounced on the right side than the left, resulting from dextrorotation of the enlarging uterus and compression of the right ureter as it crosses the iliac vessels adjacent to the dilated right ovarian vein complex.

Gastrointestinal Adaptations

• Smooth Muscle Relaxation: Progesterone relaxes smooth muscle throughout the alimentary tract, causing decreased lower esophageal sphincter (LES) tone (predisposing to pyrosis), delayed gastric emptying, and prolonged colonic transit time with increased water absorption (predisposing to constipation).
• Biliary Stasis: Impaired gallbladder motility and incomplete emptying promote biliary sludge and gallstone formation, increasing the risk of cholelithiasis and intrahepatic cholestasis of pregnancy.

---

Normal Physiologic Shifts vs. Pathologic Findings

---

Stepwise Management of Common Pregnancy Discomforts

1. Nausea & Vomiting of Pregnancy (NVP) & Hyperemesis Gravidarum

NVP affects 70% to 80% of pregnant individuals. Symptoms peak between 8 and 12 weeks of gestation and typically resolve by 16 to 20 weeks.

Non-Pharmacologic Foundations

• Frequent, small-volume meals (every 1 to 2 hours) high in protein and complex carbohydrates; avoid an empty stomach.
• Keep plain crackers at the bedside to eat 15 minutes before getting out of bed.
• Separate dry foods from liquids by at least 30 minutes; drink cold, clear carbonated fluids.
• Avoid strong food odors, spicy/greasy foods, and flickering lights.
• P6 acupressure wristbands; ginger (capsules 250 mg orally four times daily, or ginger tea/chews).

Stepwise Pharmacotherapy Ladder (ACOG Guidelines)

1. First-Line Pharmacotherapy:
   • Pyridoxine (Vitamin B6): 10 to 25 mg orally 3 to 4 times daily, ALONE or COMBINED WITH
   • Doxylamine Succinate: 10 to 12.5 mg orally 3 to 4 times daily.
   • Formulations: Available as FDA-approved prescription fixed combinations (Diclegis: 10 mg/10 mg up to 4 tabs/day; Bonjesta: 20 mg/20 mg) or over-the-counter equivalents.
2. Second-Line Pharmacotherapy:
   • Add an oral or rectal H₁-receptor antagonist: Dimenhydrinate (25 to 50 mg PO/PR q4–6h) or Diphenhydramine (25 to 50 mg PO/IV q4–6h).
   • Add an oral/rectal dopamine antagonist: Promethazine (12.5 to 25 mg PO/PR/IM q4–6h) or Metoclopramide (5 to 10 mg PO/IV/IM q8h).
3. Third-Line Pharmacotherapy:
   • Serotonin 5-HT₃ receptor antagonists: Ondansetron (4 to 8 mg PO/IV q8h).
   • Safety Note: Reserve ondansetron for refractory symptoms and exercise caution prior to 10 weeks of gestation due to a small potential risk of cleft palate, and monitor for maternal QT interval prolongation.

Hyperemesis Gravidarum (HG) & Thiamine Mandate

Hyperemesis gravidarum is characterized by severe, intractable vomiting, dehydration, ketonuria, electrolyte derangements (hypokalemia, hypochloremia, metabolic alkalosis), and weight loss exceeding 5% of pre-pregnancy weight.

• Inpatient Fluid Resuscitation: Intravenous replacement with normal saline or lactated Ringer's containing potassium chloride.
• THE CRITICAL THIAMINE MANDATE: Intravenous Thiamine (Vitamin B1, 100 mg) MUST be administered prior to or concurrently with any intravenous dextrose-containing infusion.

2. Gastroesophageal Reflux Disease (Pyrosis / Heartburn)

Pyrosis affects up to 80% of pregnant individuals due to progesterone-mediated lower esophageal sphincter (LES) relaxation and mechanical displacement by the expanding uterus.

• Lifestyle Modifications: Small, frequent meals; avoid eating within 2 to 3 hours of recumbency; elevate head of bed 6 inches; avoid caffeine, chocolate, peppermint, citrus, tomatoes, and fried foods.
• Step 1: Antacids: Calcium carbonate (Tums) is preferred. Avoid sodium bicarbonate (causes maternal/fetal metabolic alkalosis and fluid overload) and avoid magnesium trisilicate (fetal nephrotoxicity).
• Step 2: Histamine-2 Receptor Antagonists (H₂RAs): Oral Famotidine (20 to 40 mg daily) is safe and effective.
• Step 3: Proton Pump Inhibitors (PPIs): Oral Omeprazole (20 mg daily) or pantoprazole for refractory, erosive symptoms.

3. Round Ligament Pain

Sharp, jabbing, or dull aching unilateral or bilateral lower abdominal/groin pain radiating into the labia, occurring between 16 and 24 weeks of gestation.

• Etiology: Spasm and mechanical stretching of the fibromuscular round ligaments as the enlarging uterus ascends out of the pelvis and rotates.
• Management: Reassurance; avoid rapid postural shifts; flex hips toward abdomen when coughing or sneezing; apply local warmth (warm bath or warm compress on low heat); prenatal pelvic tilt exercises; wear a supportive maternity abdominal support belt; oral acetaminophen as needed.

4. Physiologic Leukorrhea vs. Vaginal Infection

Profuse, thin, white/clear, odorless, non-irritating vaginal discharge resulting from high estrogen-driven vaginal epithelial hyperplasia and increased cervical glandular mucus.

• Evaluation: Absence of pruritus, burning, erythema, or malodor. Wet mount reveals normal superficial squamous cells and abundant lactobacilli without clue cells, fungal hyphae, or motile trichomonads. Vaginal pH is normally acidic (<4.5).
• Management: Reassurance; wear breathable cotton underwear; use unscented panty liners. Strictly counsel against douching, internal vaginal washes, and scented hygiene products, which destroy protective Lactobacillus species and elevate risks of bacterial vaginosis and ascending infection.

5. Lumbar Lordosis & Lower Back Pain

Forward uterine growth shifts the maternal center of gravity anteriorly over the lower extremities, compensated by exaggerated lumbar lordosis, paraspinal muscle strain, and relaxin-induced sacroiliac joint laxity.

• Management: Maintain proper ergonomics (lift with knees, not back); avoid high-heeled shoes; sleep in lateral decubitus with a pillow between knees; pelvic tilt and core-strengthening exercises; maternal support belt; physical therapy; local heat/ice; acetaminophen.